Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Markwardt

Showing results (91-100 of 172) with videos related to

Pageof 18
Sort By:
Biomedica Biochimica Acta|January 1, 1988
Influence of velocity, temporal frequency and initial phase position of grating patterns on motion VEPF Markwardt, E Göpfert, R Müller
Die Pharmazie|June 1, 1982
[Animal experiments on the pharmacokinetics of N alpha-tosyl-(3-amidinophenyl)alanine piperidide (TAPAP), a new thrombin inhibitor]J Hauptmann, F Markwardt, M Richter
Thrombosis Research|June 1, 1989
Studies on antithrombotic effects of recombinant hirudinF Markwardt, B Kaiser, G Nowak
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1988
Prevention of experimental coronary thrombosis by hirudinE Bucha, G Nowak, F Markwardt
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1988
Pharmacokinetic studies with recombinant hirudin in dogsG Nowak, F Markwardt, E Fink
Die Pharmazie|February 1, 1987
[The pharmacodynamics of synthetic thrombin inhibitors of the basic type substituted n-alpha arylsulfonylated phenylalanine amide]B Kaiser, J Hauptmann, F Markwardt
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1984
[Activation of the fibrinolytic system with dehydrochlormethyltestosterone]A Hoffmann, H P Klöcking, F Markwardt
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1985
Changes of haemostaseological variables in carbon tetrachloride poisoning in ratsH P Klöcking, H Müller, F Markwardt
Pathologie-Biologie|February 1, 1987
[Release of plasminogen activator by SIN-1]H P Kloecking, A Hoffmann, F Markwardt
Haemostasis|January 1, 1987
Release of plasminogen activator by batroxobinH P Klöcking, A Hoffmann, F Markwardt
Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:
Pageof 18
Biomedica Biochimica Acta|January 1, 1988
Influence of velocity, temporal frequency and initial phase position of grating patterns on motion VEPF Markwardt, E Göpfert, R Müller
Die Pharmazie|June 1, 1982
[Animal experiments on the pharmacokinetics of N alpha-tosyl-(3-amidinophenyl)alanine piperidide (TAPAP), a new thrombin inhibitor]J Hauptmann, F Markwardt, M Richter
Thrombosis Research|June 1, 1989
Studies on antithrombotic effects of recombinant hirudinF Markwardt, B Kaiser, G Nowak
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1988
Prevention of experimental coronary thrombosis by hirudinE Bucha, G Nowak, F Markwardt
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1988
Pharmacokinetic studies with recombinant hirudin in dogsG Nowak, F Markwardt, E Fink
Die Pharmazie|February 1, 1987
[The pharmacodynamics of synthetic thrombin inhibitors of the basic type substituted n-alpha arylsulfonylated phenylalanine amide]B Kaiser, J Hauptmann, F Markwardt
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1984
[Activation of the fibrinolytic system with dehydrochlormethyltestosterone]A Hoffmann, H P Klöcking, F Markwardt
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1985
Changes of haemostaseological variables in carbon tetrachloride poisoning in ratsH P Klöcking, H Müller, F Markwardt
Pathologie-Biologie|February 1, 1987
[Release of plasminogen activator by SIN-1]H P Kloecking, A Hoffmann, F Markwardt
Haemostasis|January 1, 1987
Release of plasminogen activator by batroxobinH P Klöcking, A Hoffmann, F Markwardt
Pageof 18